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Abstract
Background: Pyogenic liver abscesses are currently treated by either percutaneous computer tomog-
raphy (CT)-guided drainage or by laparoscopic and a conventional liver resection when conservative
treatment fails but may be associated with substantial morbidity and mortality.
Methods: A minimally invasive technique involving debridement of right liver abscesses was
employed using a minimally invasive video-assisted hepatic abscess debridement (VAHD) after unsuc-
cessful percutaneous CT-guided drainage. Clinical data, complication rates and outcomes of patients
were recorded retrospectively.
Results: Between 2011 and 2014, VAHD was performed on 10 patients at two centres with no
observed recurrence of a liver abscess. The median age of the patients was 57 years (range 42–78)
with a median pre-operative size of a liver abscess of 78 mm (range 40–115). The median operation
time was 47 min (range 23–75), and the median postoperative hospital stay was 9 days (range 7–69).
One patient developed a subcutaneous abscess that required further surgery. No patient died, and
there were no major complications related to the VAHD.
Conclusions: Video-assisted hepatic abscess debridement is a feasible technique that shows promis-
ing results for the treatment of a recurrent right liver abscess.
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Introduction
Liver abscesses are common, and treatment is often challeng-
ing. Advanced imaging techniques may enable ready identifica-
tion of small lesions in their initial stages. Aggressive
treatments have given way to minimally invasive procedures
such as ultrasound (US) or computer tomographic (CT)-
guided percutaneous or laparoscopic drainage.1,2 Percutaneous
management combined with systemic antibiotics is effective
and safe and resolves most liver abscesses. However, a small
proportion of patients may require surgical drainage.3
A similar problem exists for necrotizing pancreatitis, in which
the video-assisted retroperitoneal debridement (VARD) proce-
dure provides an excellent alternative to necrosectomy by lapa-
rotomy or CT-guided percutaneous drainage in the treatment of
infected necrotizing pancreatitis (INP). Although pancreatic
necrosis and hepatic abscesses are very different pathological
processes, the minimally invasive VARD procedure was adopted
for the therapy of persistent or therapy refractory liver abscesses
in this study.4
Patients and methods
Patient information
Informed consent was obtained from patients with an intrapa-
renchymal right-sided liver abscess and were operated at the
Department of General, Visceral and Transplantation Surgery,
RWTH Aachen University Hospital, Germany and at the
Department of Surgery, Maastricht University Medical Centre,
The Netherlands. Basic demographic data (age, gender, medical
history including previous operations, previous percutaneous
drainage, the size of the liver abscess, operation time, bacteriol-
ogy and duration of hospital stay) were recorded.
Management protocol
Patients were selected for video-assisted hepatic abscess
debridement (VAHD) on the basis of having persistent clinical
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and radiological features of a liver abscess. In both centres, a
liver abscess was normally managed by antibiotic therapy based
on culture sensitivities of blood or pus. Antibiotic therapy
alone was normally employed for patients with small, non-
accessible abscess formation. Percutaneous drainage was
employed for patients with accessible abscesses. Only patients
whose abscess had not resolved with at least one percutaneous
radiological drainage procedure were considered for VAHD.
Antibiotic therapy was normally continued for at least 7 days.
Monitoring of patients was normally undertaken by serial com-
puter tomography (CT). Resolution of a liver abscess was
based on control CT, clinical and laboratory parameters.
Technique of VAHD procedure
Pre-operatively a CT-guided percutaneous drainage was placed
within the liver abscess to assist operative guidance (Fig. 1).
Placement of the percutaneous drainage was planned individu-
ally, and CT-guided drainage was performed. The drain was
placed radiologically as posterior as possible on the flank.
Video-assisted retroperitoneal debridement of the liver abscess
was performed under general anaesthesia. The patient was
placed in a left lateral position with the right hand over the
head (Fig. 2). A spindle-shaped excision was performed at the
site of percutaneous drainage that was used as a guide to reach
the abscess cavity from which purulent material was aspirated
using a laparoscopic suction device. Visualization of the abscess
cavity was achieved using a 10-mm 0 degree Videoscope
(Storz, Tuttlingen, Germany) and the outer necrotic abscess
capsule was removed carefully with a long grasping forceps.
Further debridement of necrotic liver tissue was performed
carefully using 5-mm laparoscopic instruments.
After performing the debridement, the cavity was irrigated
with sterile saline until the suction-fluid became clear. Haemo-
stasis was secured using a bipolar or argon laser. The abscess
cavity was drained by a 16°F-gauge irrigation suction drainage
sutured to the skin. Continuous post-operative lavage with 2 l
of normal saline per day was performed until serous quality of
lavage fluid was observed. Drainage was discontinued after that
and secondary wound healing intended.
Results
Between December 2011 and October 2013, 10 patients had
undergone a minimum of one unsuccessful percutaneous
CT-guided liver drainage before VAHD was attempted (Table 1).
The median age of the patients (seven male) was 57 years
(range 42–78). The pre-operative median size of the liver
abscess was 78 mm (range 40–115) and the median number of
unsuccessful percutaneous CT-guided liver drainage before
VAHD procedure was 2 (range 1–5). The median operation
time was 47 min (range 23–75). No recurrent liver abscess
occurred, and no major post-operative complication was
detected. In one patient, a subcutaneous abscess required surgi-
cal intervention. The hospital stay ranged from 7 to 69 days
with a median stay of 9 days. The mean duration of follow-up
was 3 months.
(a)
(c)
(b)
(d)
Figure 1 (a and b) demonstrate a typical right hepatic abscess and a follow-up computed tomography (CT) at 3 months after video-
assisted hepatic abscess debridement (VAHD) (c, d)
HPB 2015, 17, 732–735 ª 2015 International Hepato-Pancreato-Biliary Association
HPB 733
(a)
(c)
(b)
(d)
Figure 2 Pre-operative situation with the guidance drainage in the right upper flank (a); pre-operative situation with the guidance
drainage in the right upper flank after disinfection (b); spindle-shaped excision around the guidance drainage (c). Excised liver abscess
after debridement with a lavage-suction 16 F-drain sutured to the skin (d)
Table 1 Patients’ details
Gender Age Diagnosis Number of
CT-guided
drainage
before VAHD
Size of liver
abscess (mm)
Operation
time (min)
Complications
Patient 1 Female 78 Liver resection for
gallbladder
carcinoma
1 80 23 None
Patient 2 Male 42 Chronic pancreatitis 2 76 49 Post-operative
subcutaneous
abscess
Patient 3 Male 61 Pylorus preserving
panreaticoduodenectomy
for cholangiocarcinoma
2 40 37 None
Patient 4 Male 52 Complicated course after
cholecytectomy
2 85 28 None
Patient 5 Male 40 Amboebiasis 3 71 65 None
Patient 6 Female 70 Trisecton ectomy due
to Klatskin tumor
4 115 43 None
Patient 7 Male 72 Pylorus preserving
panreaticoduodenectomy
for pancreatic carcinoma
5 85 59 None
Patient 8 Female 44 Liver resection for adenoma 1 93 45 None
Patient 9 Male 45 Superior mesenteric artery
stenosis for aortal
recontruction
1 63 75 None
Patient 10 Male 64 Pylorus preserving
panreaticoduodenectomy
for pancreatic carcinoma
1 52 53 None
HPB 2015, 17, 732–735 ª 2015 International Hepato-Pancreato-Biliary Association
734 HPB
Microbiological examination of abscess material demon-
strated a variety of organisms including Pseudomonas aerogin-
osa, Staphylococcus epidermidis, Proteus mirabilis, Enterococcus
faecium, Streptococcus pyogenes, Fusobacterium nucleatum,
Escherischa coli, Streptococcus constellatus, Klebsiella oxytoca,
Enterococcus faecalis, vancomycin-resistant enteroccocus (VRE)
and methicillin-resistant staphylococcus aureus (MRSA).
Discussion
Of the different methods available in the treatment of the pyo-
genic liver abscesses, singular antibiotic therapy is the first
choice of treatment for small multiple abscesses.5 Percutaneous
drainage has largely replaced surgical drainage as a first-line
treatment with a success rate of 70–90% for solitary and uni-
locular abscesses.6
Failure of this therapy strategy include catheter obstruction by
pus, retained intra-abscess debris, the presence of multiloculated
abscesses, immunocompromised patients, inappropriate catheter
placement or premature removal of drains.7 Retained debris or
adhesive content of the abscess may occur in patients with sec-
ondarily infected, necrotic segments of the liver and evacuation
of these areas can be problematic. A small proportion of patients
with a liver abscess may, therefore, require surgical drainage. In
the report of Zerem et al.,3 percutaneous needle aspiration was
performed in 116 patients, with 70 later requiring percutaneous
catheter drainage owing to abscess recurrence. In 148 patients,
percutaneous catheter drainage had been performed initially but
was required twice or more in 63 patients. Percutaneous treat-
ment was the definitive successful treatment in 230 of 264
patients (87%) but 20 patients (8%) required surgery.3 Up until
now, there have been no randomized controlled trials to com-
pare percutaneous to surgical drainage techniques. The failure
rate can be expected to be higher in the percutaneous group
owing to the smaller caliber drainage of the catheters, as well as
the insufficiency of necrosectomy and debridement of necrotic
liver areas within the abscess.7 If percutaneous drainage fails, all
surgical accessible liver abscesses are candidates for laparoscopic
intervention.1,8 However, when previous abdominal surgery has
been performed, a laparoscopic approach might not be the
preferred choice.
In this study, the VARD was adopted for recurrent liver
abscesses in patients in which a laparoscopic approach did not
seem to be favourable. The VARD procedure has been
described as a safe and efficient procedure for infected pancre-
atic walled-off necrosis with low mortality and complication
rates.9 As with VARD, the VAHD has been associated with low
complication rates. Only one patient required reoperation
owing to a recurrent subcutaneous abscess.
The VAHD procedure seems to be a feasible procedure with a
manageable operation time. The present approach with video
examination allows visualization of the cavity and irrigation until
the suction fluid is clear. It also allows identification of necrotic
liver areas and offers the possibility of performing proper debride-
ment. The appropriate time point for this intervention is most
probably not at the beginning of abscess formation as an
established pyogenic membrane keeps the risk for injury of liver
vasculature or the biliary tree to a minimum.
This report represents only a description of the feasibility of
the technique. Further large randomized trials would be
required to prove the superiority of VAHD over laparoscopic
or open drainage in patients with recurrent liver abscesses in
which percutaneous CT-guided drainage fails.
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